序号 |
标题 |
次数 |
作者 |
发布时间 |
86536 |
DOTA-RGD,DOTA多肽衍生物 |
113 |
kx |
2024-11-21 |
86537 |
DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 |
107 |
zcy |
2024-11-21 |
86538 |
DOTA-丙烯酰胺,DOTA Acrylamide |
100 |
kx |
2024-11-21 |
86539 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
95 |
zyl |
2024-11-21 |
86540 |
1262403-91-7,七肽DOTA-YLYEIAR,螯合物前体肽 |
92 |
kx |
2024-11-21 |
86541 |
DOTA-8-AOC-BBN (7-14)NH2 NOTA-共轭铃蟾肽衍生物 |
99 |
zcy |
2024-11-21 |
86542 |
多叠氮基聚乙二醇衍生物(PEGn(N3))m |
91 |
WYQ |
2024-11-21 |
86543 |
DOTA derivative,CAS号:153777-70-9 |
84 |
zyl |
2024-11-21 |
86544 |
多炔基聚乙二醇衍生物(PEGn(C≡CH))m |
129 |
WYQ |
2024-11-21 |
86545 |
173308-19-5,DOTA-(COOt-Bu)3-C2-NH2 |
82 |
kx |
2024-11-21 |
86546 |
DOTA-ADIBO,CAS号:1374865-01-6 |
88 |
zyl |
2024-11-21 |
86547 |
端炔基聚乙二醇(PEG-alk) |
171 |
WYQ |
2024-11-21 |
86548 |
Gd-DOTA-HCBP(多肽核磁共振成像(MRI)探针) |
98 |
zyl |
2024-11-21 |
86549 |
NOTA-IPB-PDL1P PET成像分子探针 |
93 |
zcy |
2024-11-21 |
86550 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
95 |
zyl |
2024-11-21 |
86551 |
DOTA-E[c(RGDyK)2],金属离子螯合剂 |
99 |
kx |
2024-11-21 |
86552 |
DOTA-8-AOC-BOMBESIN(7-14)NH2 DOTA-8-AOC-铃蟾肽(7-14)氨基 |
91 |
zcy |
2024-11-21 |
86553 |
DOTA-Arg-Gly-Asp-Ser-Pro-Lys-COOH |
130 |
kx |
2024-11-21 |
86554 |
GGG-PEG4-DOTA |
81 |
zyl |
2024-11-21 |
86555 |
叠氮化四乙酰基葡萄糖(TAGP-N3) |
100 |
WYQ |
2024-11-21 |
86556 |
DOTA-SP(4-11) DOTA偶联神经肽P物质(SP) |
88 |
zcy |
2024-11-21 |
86557 |
叠氮端基聚(γ-苄基-L-谷氨酸酯)(PBLG-N3) |
168 |
WYQ |
2024-11-21 |
86558 |
DOTA-E[cyclo(RGDfK)2] |
83 |
kx |
2024-11-21 |
86559 |
DOTA-(COOt-Bu)3-NHS,819869-77-7 |
83 |
zyl |
2024-11-21 |
86560 |
三乙炔基苯由一个苯环和三个乙炔基取代基组成 |
184 |
WYQ |
2024-11-21 |
86561 |
DOTA-JR11,1039726-31-2是多肽分子探针前体 |
96 |
zyl |
2024-11-21 |
86562 |
DOTA-3/F11 DOTA标记的抗PSMA单克隆抗体3/F11 |
80 |
zcy |
2024-11-21 |
86563 |
DOTA-Tyr-Lys-DOTA大环化合物-多肽链 |
82 |
kx |
2024-11-21 |
86564 |
DOTA-cyclo(RGDfK) |
88 |
zyl |
2024-11-21 |
86565 |
DOTA-6G-RGD4 DOTA标记的环RGD肽 |
111 |
zcy |
2024-11-21 |
86566 |
DOTA多肽试剂1306310-00-8 |
97 |
zyl |
2024-11-21 |
86567 |
250612-06-7,DOTA多肽探针二聚体 |
79 |
kx |
2024-11-21 |
86568 |
DOTA-[D-Asp26,Nle28,31]-CCK(26-33) DOTA偶联非硫酸化CCK八肽类似物 |
110 |
zcy |
2024-11-21 |
86569 |
DOTA-GGGA,149206-86-0 |
86 |
zyl |
2024-11-21 |
86570 |
DOTA功能螯合剂标记多肽 |
131 |
kx |
2024-11-21 |
86571 |
3-双(叠氮甲基)环氧丁烷-四氢呋喃(BAMO-THF) |
137 |
WYQ |
2024-11-21 |
86572 |
DOTA-[Pro~1, Tyr~4]-bombesin 缀合肽DOTA-[Pro~1,Tyr ~ 4]-铃蟾肽 |
101 |
zcy |
2024-11-21 |
86573 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
134 |
zyl |
2024-11-21 |
86574 |
端炔基遥爪型聚酰亚胺(API) |
172 |
WYQ |
2024-11-21 |
86575 |
Dotatate(DOTA-octreotide),大环配体多肽 |
127 |
kx |
2024-11-21 |
86576 |
端炔基的线形聚(N-异丙基丙烯酰胺)(alkynylPNIPAM) |
140 |
WYQ |
2024-11-21 |
86577 |
DOTA-PEG-RGD |
100 |
zyl |
2024-11-21 |
86578 |
1,5-二叠氮基-3-硝基-3-氮杂戊烷(DIANP) |
111 |
WYQ |
2024-11-21 |
86579 |
β-炔基-氟磺酰基烷烃(BAFSAs) |
186 |
WYQ |
2024-11-21 |
86580 |
金属离子螯合剂DOTA功能化量子点 |
160 |
kx |
2024-11-21 |